HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kaposi's varicelliform eruption in mycosis fungoides.

Abstract
Kaposi's varicelliform eruption, caused by herpes simplex type 1, developed in a patient with mycosis fungoides four days after initiation of photochemotherapy with methoxsalen plus long-wave ultraviolet light (PUVA). He had a history of recurrent localized herpes infection. Vidarabine (adenine arabinoside) was used as treatment. Rechallenge with PUVA did not provoke another herpes infection. Kaposi's varicelliform eruption is rare in mycosis fungoides. Vidarabine may prove to be useful in the treatment of widespread herpes simplex.
AuthorsR J Segal, W Watson
JournalArchives of dermatology (Arch Dermatol) Vol. 114 Issue 7 Pg. 1067-9 (Jul 1978) ISSN: 0003-987X [Print] United States
PMID210713 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vidarabine
  • Methoxsalen
Topics
  • Humans
  • Kaposi Varicelliform Eruption (complications, drug therapy, immunology, microbiology)
  • Male
  • Methoxsalen (adverse effects, therapeutic use)
  • Middle Aged
  • Mycosis Fungoides (complications, therapy)
  • Photochemotherapy (adverse effects)
  • Simplexvirus
  • Skin Neoplasms (complications, therapy)
  • Ultraviolet Therapy
  • Vidarabine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: